Drug recall · September 1, 2021
FLUDARABINE PHOSPHATE FOR INJECTION recall
Why: Lack of Assurance of Sterility: the manufacturing firm had microbial recoveries during environmental monitoring in aseptic areas of manufacturing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
FLUDARABINE PHOSPHATE FOR INJECTION, USP, 50 mg per vial, Single dose vial, Rx Only, Mfd for: Leucadia Pharmaceuticals Carlsbad, CA 92011 U.S.A, NDC 24201-237-01
- Lots / codes
Lot# 31327913C, Exp. Date 10/2022
- Quantity
- 19,384 vials
- Company
- Custopharm, Inc., Carlsbad, CA
- Distribution
- Distributed Nationwide in the USA
- Initiated
- July 30, 2021 · Voluntary: Firm initiated
- Classified
- August 23, 2021
- Reported
- September 1, 2021
- Ended
- August 8, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fludarabine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.